Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Gene Therapy: "It is so new ... I wanted to see more success stories before I committed to it," said Davis, who is studying ...

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The border crisis has been an albatross around Kamala Harris’ neck — and now her jewelry is too.

Phuket is a province in the south of Thailand. Phuket's beaches face the Andaman Sea allowing the west coast beaches fantastic sunsets right throughout the year. If ...